Merck KGaA is latest bi-curious antibody developer in ADC deal with Sutro
Merck KGaA has partnered with bispecific antibody firm Sutro Biopharma to develop and produce antibody drug conjugates (ADCs).
Archives for September 16, 2014
'Fastest way to biosimilar approval? As the CRO flies,' says industry group
Almost all of the biosimilars currently approved have been developed using a third-party research organisation according to a survey from the Association of Clinical Research Organizations (ACRO).
Dispatches from ChemOutsourcing
CMO consolidation: Do biopharma partners see any benefits?
As contract manufacturers continue to consolidate, some in the industry are questioning whether the resulting companies have the ability to offer the same services as the former individual companies.